# DESCRIPTION

## TECHNICAL FIELD

- relate to inducing differentiation of pluripotent stem cells

## BACKGROUND ART

- introduce kidney function
- describe kidney disorders
- discuss therapeutic methods for kidney failure
- motivate pluripotent stem cells for kidney therapy

## DISCLOSURE OF THE INVENTION

### Problem to be Solved by the Invention

- motivate growth factor-free differentiation method

### Means for Solving the Problem

- introduce specific compound-based differentiation method
- describe method steps
- specify GSK-3 beta inhibitor and retinoic acid derivative
- detail human pluripotent stem cell types
- characterize intermediate mesoderm cells
- describe culture period and medium composition
- introduce kit for producing intermediate mesoderm cells

### Effects of the Invention

- summarize advantages of growth factor-free method
- describe benefits of retinoic acid derivative use

## EMBODIMENTS FOR CARRYING OUT THE INVENTION

- introduce pluripotent stem cells

### <Pluripotent Stem Cells>

- define pluripotent stem cells
- describe characteristics of pluripotent stem cells
- list examples of pluripotent stem cells
- introduce embryonic stem cells
- describe establishment of ES cells
- describe properties of ES cells
- provide references for ES cells
- describe maintenance of ES cells
- provide example of medium for ES cells
- describe selection of ES cells
- introduce germline stem cells
- describe properties of germline stem cells
- describe establishment of germline stem cells
- introduce embryonic germ cells
- describe properties of embryonic germ cells
- describe establishment of embryonic germ cells
- introduce induced pluripotent stem cells
- describe properties of iPS cells
- describe establishment of iPS cells
- list nuclear reprogramming substances
- describe introduction of nuclear reprogramming substances
- describe vectors for nuclear reprogramming
- describe promoters for nuclear reprogramming
- describe selection markers for nuclear reprogramming
- describe reporter genes for nuclear reprogramming
- describe transposon-mediated nuclear reprogramming
- describe episomal nuclear reprogramming
- describe polycistronic expression of nuclear reprogramming substances
- describe histone deacetylase inhibitors for nuclear reprogramming
- describe DNA methyltransferase inhibitors for nuclear reprogramming
- describe G9a histone methyltransferase inhibitors for nuclear reprogramming
- describe L-channel calcium agonists for nuclear reprogramming
- describe p53 inhibitors for nuclear reprogramming
- describe Wnt signaling activators for nuclear reprogramming
- describe ALK5 inhibitors for nuclear reprogramming
- describe mitogen-activated protein kinase signaling inhibitors for nuclear reprogramming
- describe glycogen synthase kinase-3 inhibitors for nuclear reprogramming
- describe miRNA for nuclear reprogramming
- describe culture methods for iPS cells

### (A) Step of Culturing Pluripotent Stem Cells (e.g., Human Pluripotent Stem Cells) in a Medium Containing a GSK-3 Beta Inhibitor or a GSK3-Beta Inhibitor and a Retinoic Acid Derivative (First Step)

- introduce pluripotent stem cell culture
- describe adhesion culture
- describe suspension culture
- list coating agents
- describe basal medium
- list serum substitutes
- list additional medium components
- define GSK-3 beta inhibitor
- list GSK-3 beta inhibitors
- describe CHIR99021
- list CHIR99021 concentrations
- define retinoic acid derivative
- list retinoic acid derivatives
- describe AM580 and TTNPB
- list AM580 and TTNPB concentrations
- describe ROCK inhibitor
- list ROCK inhibitors
- describe Y-27632
- list Y-27632 concentrations

### (B) Step of Culturing Pluripotent Stem Cells (e.g., Human Pluripotent Stem Cells) in Medium Containing Retinoic Acid Derivative (Second Step)

- introduce second step
- describe adhesion culture
- describe basal medium
- list serum substitutes
- list additional medium components
- describe retinoic acid derivative
- list AM580 and TTNPB concentrations
- describe culture conditions

### <Method for Producing Metanephric Cells>

- define metanephric cells
- specify cell types included in metanephric cells
- describe markers for metanephric cells
- specify medium for adhesion culture
- list examples of basal medium
- describe serum substitutes
- list additional substances for medium
- specify growth factors
- describe culture conditions
- specify CO2 concentration
- describe culture term
- isolate intermediate mesoderm cells using OSR1
- use flow cytometer for isolation
- describe method for producing luminal structure by forming sphere
- define renal tubule cells
- specify markers for renal tubule cells
- describe suspension culture
- specify medium for suspension culture
- describe culture conditions for suspension culture
- isolate intermediate mesoderm cells using OSR1

### <Intermediate Mesoderm Cells>

- identify intermediate mesoderm cells using markers

## EXAMPLES

- describe OSR1-GFP reporter iPS cell line establishment

### Establishment of OSR1-GFP-Knocked-in Human iPS Cell Line

- describe OSR1-GFP reporter iPS cell line establishment

### Induction of Differentiation into Intermediate Mesoderm Cells (Known Method: International Patent Application No. PCT/JP2011/067181 (WO 2012/011610))

- describe known method for inducing differentiation
- describe cell culture and medium preparation

### Induction of Differentiation into Intermediate Mesoderm Cells (Novel Induction Method 1)

- describe novel induction method 1
- describe cell culture and medium preparation

### Induction of Differentiation into Intermediate Mesoderm Cells (Novel Induction Methods 2 and 3)

- describe novel induction methods 2 and 3
- describe cell culture and medium preparation
- describe flow cytometry analysis
- describe results of novel induction methods 2 and 3

### Long Term Culture

- describe long term culture method
- describe cell culture and medium preparation
- describe isolation of GFP positive cells
- describe further differentiation into renal precursor cells
- describe RT-PCR analysis
- describe immunostaining analysis
- describe results of long term culture
- describe potential of OSR1 positive cells
- describe development into kidney cells

## INDUSTRIAL APPLICABILITY

- describe industrial applicability of present invention

